Adams Clinical Acquires InSite Clinical Research

Adams Clinical Acquires InSite Clinical Research

December 11, 2024

Healthcare Services

Adams Clinical, a neuroscience-focused clinical trial site network, has agreed to acquire/partner with InSite Clinical Research to add inpatient and schizophrenia clinical trial capabilities and expand into Texas. The deal will also enable Adams to establish inpatient units at its Watertown, MA and Bronx, NY sites; Provident Healthcare Partners served as exclusive financial advisor to InSite.

InTandem Capital Partners Makes Growth Investment in Adams Clinical

May 21, 2024

Healthcare Services

InTandem Capital Partners, a healthcare-focused private equity firm, has partnered with the founders and management team of Adams Clinical, a Watertown, Massachusetts–based clinical trial site network focused on psychiatric and neurologic indications. The investment will support Adams Clinical’s growth and development of its site network and patient recruitment capabilities to better serve pharmaceutical sponsors and CROs.

InTandem Capital Partners Invests in Clinilabs

March 12, 2025

Healthcare Services

InTandem Capital Partners has made a strategic growth investment in Clinilabs, a global full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug and device development. The partnership with Clinilabs’ founder and management will support scaling the company’s neuroscience trial capabilities across Phase 1–3 and accelerate commercial and operational growth.

Headlands Research Acquires Pharmasite Research

February 29, 2024

Healthcare Services

Headlands Research, a multinational network of clinical trial sites, has acquired Pharmasite Research, a Maryland-based clinical trial site focused on mental illness and central nervous system (CNS) disorders. The deal expands Headlands' therapeutic capabilities in mental health and extends its site network's reach in the Mid-Atlantic, bringing the network to 18 sites across the United States and Canada.

Atlas Clinical Research Acquires Suburban Research Associates

July 12, 2023

Healthcare Services

Atlas Clinical Research, a therapeutically-driven clinical site network and portfolio company of healthcare investor BPOC, has added Suburban Research Associates — a two-location psychiatric clinical research site in Media and West Chester, Pennsylvania — to its platform. The partnership will expand Atlas's site network and give Suburban access to centralized technology, operational support and broader sponsor/CRO connectivity to accelerate psychiatric clinical trials and patient reach.

PhaseWell Research Acquires Bio Behavioral Health

January 21, 2026

Healthcare Services

PhaseWell Research, a national clinical research site company, announced that Bio Behavioral Health has joined its network to expand access to neuropsychiatric and CNS clinical trials. The deal strengthens PhaseWell's community-based research capabilities and broadens patient access to complex clinical studies across its growing national footprint.